MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1
Clinical trials for MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1 explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1 trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could removing certain immune cells prevent a deadly transplant complication?
Disease control Recruiting nowThis study tests whether removing a specific type of immune cell (naive T cells) from donor stem cells can prevent chronic graft-versus-host disease (GVHD) in children and young adults with blood cancers. GVHD occurs when donor cells attack the patient's body after a stem cell tr…
Matched conditions: MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New transplant recipe aims to tame Graft-Versus-Host disease
Disease control Recruiting nowThis study tests a stem cell transplant using a reduced-intensity conditioning regimen (lower doses of chemotherapy and radiation) followed by a donor stem cell infusion. The goal is to treat various blood cancers and blood disorders while lowering the risk of graft-versus-host d…
Matched conditions: MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS-1
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC